Substantial Disparities Seen in Cancer Cases, Deaths Among Men

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 12, 2024 -- There are substantial disparities in cancer cases and deaths among men, which are projected to widen by 2050, according to a study published online Aug. 12 in Cancer.

Habtamu Mellie Bizuayehu, Ph.D., from the University of Queensland in Brisbane, Australia, and colleagues analyzed 30 cancer types among men in 2022 using GLOBOCAN estimates for men in 185 countries/territories worldwide and estimated projections for 2050. By dividing age‐standardized mortality rates by incidence rates, mortality-to-incidence ratios (MIRs) were calculated.

The researchers found that a high MIR was seen among older men (aged 65 years and older), for rare cancer types, and in countries with a low Human Development Index (HDI; 61, 91, and 74 percent, respectively) in 2022. Cancer cases are projected to increase from 10.3 to 19 million between 2022 and 2050 (≥84 percent), while deaths are projected to increase from 5.4 to 10.5 million (≥93 percent), with a more than twofold increase among men aged 65 years and older and for low- and medium-HDI countries/territories (≥117 and ≥160 percent, respectively). Among working-age groups and very high-HDI countries/territories, cancer cases and deaths are projected to increase (≥39 and ≥50 percent, respectively).

"A national and international collaboration, as well as a coordinated multisectoral approach, are essential to improve current cancer outcomes and to reverse the anticipated rise in cancer burden by 2050," Bizuayehu said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-13 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords